Description
Advanced Post-Treatment Healing Dermagen Egensia Cream provides advanced healing for damaged or compromised skin. It works perfectly as an intensive post-procedure recovery treatment. Consequently, it soothes redness and severe irritation immediately. Thus, you achieve a calm, comfortable complexion quickly after clinical procedures.
Cellular Repair and Regeneration The formula features Epidermal Growth Factor to speed up cellular repair. First, this powerful protein stimulates natural tissue regeneration. Second, Centella Asiatica reduces underlying inflammation effectively. Furthermore, it prevents unwanted scarring and promotes a flawless recovery. Therefore, your skin bounces back from harsh treatments safely and efficiently.
Deep Barrier Restoration This healing cream also rebuilds your protective moisture barrier. It delivers deep, lasting hydration to dry or peeling areas. As a result, it prevents the rapid water loss often experienced after aesthetic treatments. The rich texture absorbs smoothly without feeling heavy or greasy. So, your face stays incredibly soft and nourished throughout the day.
Professional Recovery Daily Professionals highly recommend this product after laser treatments, microneedling, or chemical peels. It also serves as an excellent daily moisturizer for highly sensitive skin types. Moreover, you can apply it safely to irritated areas on both the face and body. Thus, it offers versatile, powerful relief for any skin trauma.
Key Benefits:
-
Rapid Healing: Accelerates tissue repair after lasers, microneedling, and chemical peels safely.
-
Cellular Regeneration: Uses Epidermal Growth Factor to stimulate cell turnover and prevent post-treatment scarring.
-
Soothing Relief: Centella Asiatica calms redness, heat, and severe inflammation instantly.
-
Barrier Restoration: Rebuilds the natural moisture shield to prevent post-procedure dryness.
-
Gentle Daily Use: Provides a safe, non-greasy moisturizer for highly sensitive or compromised skin.












Reviews
There are no reviews yet.